Evidence map›Paper›PMID 41915291›Full record

ArticleAIDS and behavior2026

Changes in Stimulant Use Over Time Among Men Who Have Sex with Men in Philadelphia, Baltimore, and Washington, DC, 2008-2023.

Danielle German, Tanner Nassau, Karine Yenokyan, Xinyi Li, Sydney Bornstein, Kate Drezner, Taylor Hoj, Molly Gribbin, Colin Flynn, Kathleen A Brady and 1 more

Abstract read
In one paragraph

Article in AIDS and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Danielle GermanDepartment of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Behavior and Society, 615 North Wolfe Street, Baltimore, MD, USA. danielle.german@jhu.edu.ORCID http://orcid.org/0000-0001-9604-5817
Tanner NassauPhiladelphia Department of Public Health, Philadelphia, PA, USA.
Karine YenokyanDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Xinyi LiDistrict of Columbia Department of Health, Washington, DC, USA.
Sydney BornsteinDepartment of Epidemiology, George Washington University Milken Institute School of Public Health, Washington, DC, USA.
Kate DreznerDistrict of Columbia Department of Health, Washington, DC, USA.
Taylor HojDistrict of Columbia Department of Health, Washington, DC, USA.
Molly GribbinMaryland Department of Health, Baltimore, MD, USA.
Colin FlynnMaryland Department of Health, Baltimore, MD, USA.
Kathleen A BradyPhiladelphia Department of Public Health, Philadelphia, PA, USA.
Irene KuoDepartment of Epidemiology, George Washington University Milken Institute School of Public Health, Washington, DC, USA.

Funding

Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Anna Palmer Durbin · 2012 to 2026
$67.0M
CDC HHS 6NU62PS924769CDC HHS NU62PS924759CDC HHS NU62PS924777JG CDC HHS 6NU62PS924769JG CDC HHS NU62PS924759JG CDC HHS NU62PS924777NIAID NIH HHS P30 AI094189
6 · The paper itself

Abstract

Stimulant use among men who have sex with men (MSM) can contribute to HIV risk and care challenges. Monitoring and responding to local trends are critical for Ending the HIV Epidemic (EHE) initiatives. We assessed stimulant use patterns in Baltimore, Philadelphia, and Washington, DC from 2008 to 2023 using National HIV Behavioral Surveillance data. We collected cross-sectional data in each city using venue-based sampling in 2008, 2011, 2014, 2017, and 2023. We estimated average predicted probabilities of methamphetamine, powder cocaine, and crack cocaine use, and evaluated differences in prevalence of stimulant use overall and by race/ethnicity. In DC, stimulant use was stable or declined. Methamphetamine use remained stable overall (8%), with observed decreases among Hispanic MSM (13% to 4%). In Baltimore, methamphetamine use increased (2% to 5%) overall, while powder cocaine slightly declined overall (15% to 13%), with decreases among Black MSM but increases among White and Hispanic MSM. Crack cocaine decreased slightly (12% to 11%). In Philadelphia, methamphetamine use rose substantially (3% to 10%), with the largest increase among White MSM (3% to 19%). Powder cocaine use was highest in Philadelphia, reaching 41% among White MSM in 2023. Trends in stimulant use among MSM differed across these three EHE-funded cities. Philadelphia showed pronounced increases, particularly among White MSM, while DC and Baltimore exhibited more modest or stable patterns. Comparable local data sources are essential for identifying city- and subpopulation-specific trends to inform focused, equitable prevention strategies within EHE.

Indexed as

Central Nervous System StimulantsCocaine-Related DisordersHIV InfectionsHomosexuality, MaleMethamphetamineSubstance-Related DisordersAdultBaltimoreCocaineCrack CocaineCross-Sectional StudiesDistrict of ColumbiaHumansMaleMiddle AgedPhiladelphiaCentral Nervous System StimulantsCocaineCrack CocaineMethamphetamineCocaineCrackMethamphetamineMid-AtlanticMSMStimulants

Identifiers

PMID41915291
PMCPMC13202489

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.